Court overturns Eli Lilly's $176.5M loss in Teva patent case
US District Judge Allison Burroughs said in a post-trial ruling that the Teva patents covering the use of antibodies to inhibit headache-causing ...
US District Judge Allison Burroughs said in a post-trial ruling that the Teva patents covering the use of antibodies to inhibit headache-causing ...
Representatives from Sheba Medical Center at Tel Hashomer, Tel Aviv Sourasky Medical Center, Teva Pharmaceutical Industries among those set to ...
Pharmaceutical giant teams with Tel Aviv University, Weizmann Institute of Science to boost its early-stage drug development with a focus ...
Earlier this year, 44 US states filed a complaint in federal court alleging drug price-fixing by the three pharmaceutical companies ...
Funds to be used to fight the opioid crisis in Oklahoma, says state Attorney General Mike Hunter. Under terms of ...
Israel-based drugmaker agrees to stop selling its generic product until its license date expires in mid-2021.
The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.
All rights reserved to Israel Hayom
Hosted by sPD.co.il
[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]